Kallikrein-related peptidase 13: an independent indicator of favorable prognosis for patients with nonsmall cell lung cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Kallikrein-related peptidase 13: an independent indicator of favorable prognosis for patients with nonsmall cell lung cancer
Authors
Keywords
Lung cancer, Tissue kallikrein, Biomarker, Prognosis
Journal
TUMOR BIOLOGY
Volume 36, Issue 7, Pages 4979-4986
Publisher
Springer Nature
Online
2015-02-13
DOI
10.1007/s13277-015-3148-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sex as an Independent Prognostic Factor in a Population-Based, Non-Small Cell Lung Cancer Cohort
- (2016) Marshall W Pitz et al. Canadian Respiratory Journal
- Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies
- (2013) Manfred Schmitt et al. Radiology and Oncology
- Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance
- (2012) Margaritis Avgeris et al. BIOLOGICAL CHEMISTRY
- Diagnostic and prognostic significance of human kallikrein 11 (KLK11) mRNA expression levels in patients with laryngeal cancer
- (2012) Christos Patsis et al. CLINICAL BIOCHEMISTRY
- The kallikrein-related peptidase 13 (KLK13) gene is substantially up-regulated after exposure of gastric cancer cells to antineoplastic agents
- (2012) Dimitra Florou et al. TUMOR BIOLOGY
- Epigenetic activation of human kallikrein 13 enhances malignancy of lung adenocarcinoma by promoting N-cadherin expression and laminin degradation
- (2011) Ruey-Hwang Chou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- KLK5 gene expression is severely upregulated in androgen-independent prostate cancer cells after treatment with the chemotherapeutic agents docetaxel and mitoxantrone
- (2010) Konstantinos Mavridis et al. BIOLOGICAL CHEMISTRY
- Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing
- (2010) Julie Chao et al. BIOLOGICAL CHEMISTRY
- Kallikrein-related peptidase 13 (KLK13) gene expressional status contributes significantly in the prognosis of primary gastric carcinomas
- (2010) George Konstantoudakis et al. CLINICAL BIOCHEMISTRY
- KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma
- (2009) N M A White et al. BRITISH JOURNAL OF CANCER
- Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer
- (2009) Youwei Zhang et al. CANCER SCIENCE
- Association of O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation with p53 Mutation Occurrence in Non-Small Cell Lung Cancer with Different Histology, Gender, and Smoking Status
- (2008) Jeng-Yuan Wu et al. ANNALS OF SURGICAL ONCOLOGY
- Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung
- (2008) Chris Planque et al. BIOLOGICAL CHEMISTRY
- Human tissue kallikreins as promiscuous modulators of homeostatic skin barrier functions
- (2008) Azza Eissa et al. BIOLOGICAL CHEMISTRY
- A Multiparametric Serum Kallikrein Panel for Diagnosis of Non-Small Cell Lung Carcinoma
- (2008) C. Planque et al. CLINICAL CANCER RESEARCH
- Utility of Kallikrein-Related Peptidases (KLKs) as Cancer Biomarkers
- (2008) N. Emami et al. CLINICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started